Q3 2019 OpGen Inc Earnings Call Transcript
Welcome to the OpGen Third Quarter 2019 Earnings Call and Business Update. (Operator Instructions)
As a reminder, this conference is being recorded today, November 6, 2019. Before we begin, I would like to caution you that comments made during this conference call by management may contain forward-looking statements regarding the operations of and future results of OpGen and Curetis N.V.
I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K and 10-Q, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Factors that may affect the company's results include, but are not limited to: the completion of the business combination with Curetis N.V.; pursuit of FDA clearance for the Acuitas AMR Gene Panel for use with bacterial isolates; the use of proceeds from the October 2019 public offering; activities related to the company's products and services; the rate of adoption of its products and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |